| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) |
Mar 15 |
Mar 14 |
Mar 13 |
Mar 12 |
Mar 11 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
-10.65 |
-0.07 |
-37.57 |
-33.92 |
21.35 |
|
| Diluted EPS (Rs.) |
-10.65 |
-0.07 |
-37.57 |
-33.92 |
21.35 |
|
| Cash EPS (Rs.) |
0.08 |
11.15 |
-23.91 |
-21.60 |
33.96 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
85.38 |
91.73 |
91.56 |
132.47 |
103.88 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
85.38 |
91.73 |
91.56 |
132.47 |
103.88 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.75 |
|
| Revenue from Operations/Share (Rs.) |
110.80 |
82.06 |
97.21 |
114.29 |
187.57 |
|
| PBDIT/Share (Rs.) |
15.59 |
-13.15 |
-12.83 |
-14.10 |
46.39 |
|
| PBIT/Share (Rs.) |
4.87 |
-24.37 |
-26.46 |
-26.40 |
34.46 |
|
| PBT/Share (Rs.) |
-10.33 |
-0.07 |
-40.89 |
-42.90 |
25.37 |
|
| Net Profit/Share (Rs.) |
-10.64 |
-0.07 |
-37.54 |
-33.90 |
22.03 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
14.07 |
-16.02 |
-13.19 |
-12.33 |
24.72 |
|
| PBIT Margin (%) |
4.39 |
-29.69 |
-27.21 |
-23.10 |
18.37 |
|
| PBT Margin (%) |
-9.32 |
-0.08 |
-42.05 |
-37.53 |
13.52 |
|
| Net Profit Margin (%) |
-9.60 |
-0.08 |
-38.61 |
-29.65 |
11.74 |
|
| Return on Networth / Equity (%) |
-12.46 |
-0.07 |
-41.00 |
-25.58 |
21.20 |
|
| Return on Capital Employed (%) |
2.52 |
-14.27 |
-13.82 |
-12.26 |
18.55 |
|
| Return on Assets (%) |
-3.47 |
-0.02 |
-13.69 |
-11.21 |
7.86 |
|
| Total Debt/Equity (X) |
1.81 |
1.48 |
1.61 |
0.93 |
1.27 |
|
| Asset Turnover Ratio (%) |
36.14 |
26.66 |
35.47 |
37.81 |
66.93 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
0.45 |
0.36 |
0.64 |
0.87 |
1.26 |
|
| Quick Ratio (X) |
0.25 |
0.15 |
0.20 |
0.23 |
0.62 |
|
| Inventory Turnover Ratio (X) |
4.82 |
2.85 |
2.65 |
2.06 |
3.12 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
3.39 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
2.20 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
96.61 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
97.80 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,781.01 |
1,406.59 |
1,659.08 |
1,241.86 |
1,882.44 |
|
| EV/Net Operating Revenue (X) |
2.62 |
2.80 |
2.78 |
1.77 |
1.64 |
|
| EV/EBITDA (X) |
18.64 |
-17.45 |
-21.09 |
-14.37 |
6.62 |
|
| MarketCap/Net Operating Revenue (X) |
1.26 |
1.16 |
1.28 |
0.71 |
0.97 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
96.60 |
|
| Price/BV (X) |
1.64 |
1.03 |
1.36 |
0.62 |
1.75 |
|
| Price/Net Operating Revenue |
1.26 |
1.16 |
1.28 |
0.71 |
0.97 |
|
| Earnings Yield |
-0.08 |
0.00 |
-0.30 |
-0.41 |
0.12 |
|
Source : Dion Global Solutions Limited
